drugset
drugset / Trial / NCT01030224

This is a Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of AZD9742 After Single IV Doses in Healthy Subjects

NCT01030224 ↗

Phase 1 Completed 48 enrolled AstraZeneca Quintiles, Inc. · collab
RandomizedParallel-groupDouble-blindBasic science

Summary

The main purpose of this study is to assess the safety, tolerability and PK of AZD9742 after single IV doses.

Timeline

Start
2009-11
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD9742 Unknown — Intravenous

Indications

No indication recorded.